Evozyne

AI-engineered proteins for immune-mediated disease

Chicago, United States · Founded 2020 · $135.2M raised

Headquarters
Chicago, Illinois
Employees
51–200
Founded
2020
Business Model
B2B
Total Funding
$135.2M
Last Round
$81.0M Series BSep 2023
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 5 investors for this company. The full record is or through the API.

About

Evozyne is an AI-native biotech company that designs novel engineered protein therapeutics to address immune-mediated diseases. Founded by Paragon Biosciences, the company uses generative deep learning and high-throughput biology to create proteins with mechanisms that natural evolution never produced. Based in Chicago, Evozyne collaborates with partners including NVIDIA to accelerate the path from protein design to clinical application.

Summary

Evozyne is an Artificial Intelligence company based in Chicago, United States, founded in 2020. It has raised $135.2M in total across 2 rounds, most recently a $81.0M Series B round in Sep 2023. Investors include OrbiMed, Fidelity Management and nVentures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BSep 2023
$81.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
OpenAI

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...

San Francisco, United States5001–10000Artificial Intelligence, Generative AI
Corporate RoundTotal funding$179.6BMar 2026
Anthropic

Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...

San Francisco, United States1001–5000Artificial Intelligence, Generative AI
Series G+Total funding$123.7BMay 2026
xAI

xAI builds AI systems, including Grok, with frontier reasoning, voice, and generative media capab...

San Francisco, United States201–500Artificial Intelligence, Generative AI
Series ETotal funding$47.4BJan 2026
Waymo

Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...

Mountain View, United States1001–5000Artificial Intelligence, Autonomous Vehicles
Venture RoundTotal funding$29.6BFeb 2026
Databricks

Databricks provides a unified data and AI platform that helps enterprises build and run applicati...

San Francisco, United States10001+Analytics, Artificial Intelligence
Series G+Total funding$20.0BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Evozyne on Indexed.vc
<a href="https://indexed.vc/companies/evozyne"><img src="https://indexed.vc/api/badge/company/evozyne" alt="Evozyne on Indexed.vc" width="260" height="76" /></a>